Dr. Ricardo Rendon, MD
Claim this profileQueen Elizabeth II Health Sciences Centre
Studies Prostate Cancer
Studies Non-Muscle Invasive Bladder Cancer
6 reported clinical trials
13 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
Stage III
Stage II
2Non-Muscle Invasive Bladder Cancer
Affiliated Hospitals
Clinical Trials Ricardo Rendon, MD is currently running
PDT
for Bladder Cancer
This trial tests a new treatment for bladder cancer patients who do not respond to or cannot tolerate standard therapy. The treatment uses a drug called Ruvidar® that is activated by a special light to kill cancer cells in the bladder.
Recruiting1 award Phase 210 criteria
Darolutamide + SBRT
for Prostate Cancer
This trial tests a combination of precise radiation therapy and a hormone-blocking drug in prostate cancer patients with limited spread. It aims to control the disease and delay more toxic treatments. The approach targets small areas of cancer spread and blocks the cancer's growth signals. The hormone-blocking drug is a novel treatment approved for specific prostate cancer cases.
Recruiting2 awards Phase 23 criteria
More about Ricardo Rendon, MD
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ricardo Rendon, MD has experience with
- Peer Navigation
- Active Wait List Control
- Ruvidar® (TLD-1433)
- Darolutamide
- External Beam Radiotherapy
- Luteinizing Hormone-Releasing Hormone Analog
Breakdown of trials Ricardo Rendon, MD has run
Prostate Cancer
Non-Muscle Invasive Bladder Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ricardo Rendon, MD specialize in?
Ricardo Rendon, MD focuses on Prostate Cancer and Non-Muscle Invasive Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ricardo Rendon, MD currently recruiting for clinical trials?
Yes, Ricardo Rendon, MD is currently recruiting for 2 clinical trials in Halifax Nova Scotia. If you're interested in participating, you should apply.
Are there any treatments that Ricardo Rendon, MD has studied deeply?
Yes, Ricardo Rendon, MD has studied treatments such as Peer navigation, Active wait list control, Ruvidar® (TLD-1433).
What is the best way to schedule an appointment with Ricardo Rendon, MD?
Apply for one of the trials that Ricardo Rendon, MD is conducting.
What is the office address of Ricardo Rendon, MD?
The office of Ricardo Rendon, MD is located at: Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia B3H 2Y9 Canada. This is the address for their practice at the Queen Elizabeth II Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.